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The transmembrane S6 segments of Na+ sodium channels form the cytoplasmic
entrance of the channel and line the internal aspects of the aqueous pore. This
region of the channel has been implicated in Na+ channel permeation, gating, and
pharmacology. In this study we utilized cysteine substitutions and methanethiosulfonate
reagent (MTSET) to investigate the role of the S6 segment of homologous domain
4 (D4S6) in the gating of the cardiac (Nav1.5) channel. D4S6 cysteine mutants were
heterologously expressed in tsA201 cells and currents recorded using whole-cell patch
clamp. Internal MTSET reduced the peak Na+ currents, induced hyperpolarizing shifts
in steady-state inactivation and slowed the recovery of mutant channels with cysteines
inserted near the middle (F1760C, V1763C) and C-terminus (Y1767C) of the D4S6.
These findings suggested a link between the MTSET inhibition and fast inactivation. This
was confirmed by expressing the V1763C and Y1767C mutations in non-inactivating
Nav1.5 channels. Removing inactivation abolished the MTSET inhibition of the V1763C
and Y1767C mutants. The data indicate that the MTSET-induced reduction in current
primarily results from slower recovery from inactivation that produces hyperpolarizing
shifts in fast inactivation and decreases the steady-state availability of the channels. This
contrasted with a cysteine inserted near the C-terminus of the D4S6 (I1770C) where
MTSET increased the persistent Na+ current at depolarized voltages consistent with
impaired fast inactivation. Covalent modification of D4S6 cysteines with MTSET adduct
appears to reduce the mobility of the D4S6 segment and stabilize the channels in the
fast inactivated state. These findings indicate that residues located near the middle and
C-terminus of the D4S6 play an important role in fast inactivation.
Keywords: sodium channel, Nav1.5, D4S6, MTSET, DIVS6, Y1767, F1760, V1763
Introduction
Voltage-gated Nav1.5 Na+ channels produce the rapid upstroke of the cardiac action potential that
serves as a trigger for the downstream events leading to myocardial contraction. These channels
are important determinants of myocardium excitability, electrical conduction and are the target of
class I antiarrhythmic drugs (Nau et al., 1999; Lipkind and Fozzard, 2005; Ulbricht, 2005; Catterall
and Swanson, 2015). Naturally occurring mutations of Nav1.5 cause hereditary cardiac arrhythmias
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including Long QT type-3 (LQTS3) and Brugada syndromes
(Huang et al., 2006; Millat et al., 2009). The Nav1.5 channel α
subunit is organized into four homologous domains (D1–D4)
each composed of six transmembrane segments (S1–S6). The α
subunits encode for the basic properties of the channel including
ion permeation and voltage-dependent gating (Catterall, 2000,
2012). The S6 segments contributed by the four homologous
domains (D1S6–D4S6) of Nav1.5 converge to form the
cytoplasmic entrance of channel (Payandeh et al., 2011; Bagneris
et al., 2015). The cytoplasmic pore region includes residues that
contribute to ion permeation, channel gating and the binding of
pore-blocking drugs (Sheets et al., 2010; Catterall and Swanson,
2015).
Residues of the D4S6 segment are proposed to line the
cytoplasmic pore of Na+ channels. The exposure of speciﬁc D4S6
residues within the aqueous pore is supported by the crystal
structures of bacterial Na+ channels (Payandeh et al., 2011;
Bagneris et al., 2015). In this study we employed a combination
of mutagenesis and cysteine-speciﬁc modifying reagents to
investigate the role of the D4S6 in Na+ channel gating. The
data show that MTSET modiﬁcation of cysteines exposed within
the aqueous pore slows recovery from inactivation, produces
hyperpolarizing shifts in steady-state availability, and reduces
Na+ current amplitude. MTSET inhibition of the D4S6 mutant
Na+ currents was abolished by mutations of the interdomain
D3–D4 linker that remove fast inactivation. MTSETmodiﬁcation
of cysteines inserted near the middle and C-terminus of the
D4S6 segment alters channel gating and reduces Na+ current
amplitude.
Materials and Methods
Cell Culture
tsA201 cells were grown in DMEM (Dubelcco’s modiﬁed
Eagle’s medium) supplemented with 10% FBS, L-glutamine
(2 mM), penicillin G (100 U/ml) and streptomycin (10 mg/ml)
(Gibco BRL Life Technologies, Burlington, ON, Canada) in
a 5% CO2 incubator. The cells were transfected using a
standard calcium phosphate precipitation method (Invitrogen
Corporation, Carlsbad, CA, USA). In order to facilitate the
identiﬁcation of transfected cells, 1 μg of CD8 plasmid was
cotransfected with 1 μg of either WT or mutant Na+ channel
cDNA and incubated 24–48 h. Immediately before recording
the cells were incubated for 2 min with CD8 antibody-coated
beads (Dynabeads, Invitrogen Corporation, Carlsbad, CA, USA)
to label successfully transfected cells expressing the CD8 antigen.
Electrophysiology
Whole-cell Na+ currents of tsA201 cells expressing Nav1.5
channels were obtained using an Axopatch 200A patch clamp
ampliﬁer equipped with a DigiData 1440A interface (Axon
Instruments). Voltage pulses were generated and data collected
using pClamp Version 9.0 (Axon Instruments). Patch pipettes
fashioned from Corning 8161 glass (Warner Instruments,
Hamden, CT, USA) had resistances of 0.5–1 M, and were
coated with sylgard to reduce capacitive transients. Extracellular
solution contained (in mM): 145 NaCl, 2 KCl, 1.5 CaCl2, 1
MgCl2, and 10 HEPES pH 7.4 with NaOH. Internal solution
consisted of (in mM): 105 CsF, 35 mM NaCl, 5 EGTA, and
10 Cs-HEPES pH 7.4 with CsOH. Thiol reactive MTSET [2-
(Trimethylammonium) ethyl] methanethiosulfonate Bromide)
was obtained from Toronto Research Chemicals (Toronto, ON,
Canada). A stock solution of MTSET (100 mM) was made in
distilled water and stored on ice for less than two hours. MTSET
was diluted into internal solution to a ﬁnal concentration of 1mM
immediately prior to ﬁlling the patch pipette. The time between
pipette ﬁlling and establishing the whole-cell conﬁguration was
about 2 min. Peak amplitudes of the unmodiﬁed Na+ currents
were determined frommeasurementsmadewithin the ﬁrst 10 s of
establishing the whole-cell conﬁguration. Experiments in which
break-in induced leak or in which unstable peak currents were
observed were discarded. In these studies a cysteine situated near
external mouth of the channel (C373) of Nav1.5 was replaced with
phenylalanine (C373F) to prevent MTSET modiﬁcation at this
site.
Molecular Biology
Amino acid substitutions were made using the QuickChange
Site-Directed Mutagenesis Kit according to the supplier’s
instructions (Stratagene Inc., La Jolla, CA, USA). Mutations
substitutions were conﬁrmed by cDNA sequencing.
Data Analysis
The data are reported as the mean and SEM. The current
amplitudes of the reagent-free control and MTSET-treated cells
were compared using t-tests (p < 0.05).
Model of Closed-State Inactivation
A ﬁrst-order reaction was used to model the interconversion
between resting and inactivated states. β and α are the voltage
dependent rate constants for entering and exiting the inactivated
state, respectively. The time constants of closed-state inactivation
(τc) were ﬁtted to τ = (β + α)−1, where β(V) = β(0)exp(V/k)
and α(V) = α(0)exp(–V/k). β(0) and α(0) are the rate constants
at 0 mV, V is the test pulse voltage and k represents the voltage
dependence. In this model the steady-state probability of not
being inactivated is α/(β + α).
Steady-State Inactivation
Steady-state inactivation was measured by applying 200 ms
prepulses to voltages between –170 and –50 mV. A standard
test pulse to –10 mV for 20 ms was used to assess current
availability. The test currents were normalized to those measured
after prepulsing to –170 mV and plotted versus the prepulse
voltage. The data were ﬁt to a Boltzmann function: (I/Io = 1/[1–
exp(V0.5–V)/kv]), where I is peak test current, Io is the maximal
current measured after prepulsing to –170 mV, V0.5 is the
midpoint of inactivation and kv the slope factor reﬂecting the
voltage-sensitivity of inactivation.
Recovery from Inactivation
Depolarizing prepulses to –10 mV for 20 ms were used to
inactivate the channels before returning the membrane potential
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to –140 mV for variable intervals (0.1–250 ms). A standard
test pulse to –10 mV for 20 ms was used to assess channel
availability. The test currents were normalized to the currents
measured after 250 ms at –140 mV and plotted versus the
recovery interval. The smooth lines are biexponential curve ﬁts
[I/Io = Afast(1–exp–t/τfast) + (1–Afast)(1–exp(–t/τslow)] where
I is the amplitude of the test current, Io the amplitude of
the current measured after the 250 ms recovery interval, τfast
and τslow the fast and slow recovery time constants and
Afast the relative amplitude of the fast component (Note:
Aslow = 1–Afast).
Nav1.5 Homology Model
Homology modeling of the Nav1.5 pore-forming region was
based on the x-ray crystal structure of the NavMs bacterial Na+
channel. Model shows the predicted orientation of the Nav1.5
residues V1763 (purple), Y1767 (orange), and I1770 (cyan).
Details of the modeling are further described in Poulin et al.
(2014).
Results
Using a homology model based on bacterial Na+ channels as a
guide (Figure 2), residues of the Nav1.5 D4S6 segment predicted
to be exposed within the cytoplasmic pore were replaced with
cysteines and the mutant channels heterologously expressed in
tsA201 cells. Figure 1 compares the eﬀects of internally applied
MTSET (1 mM) on the Na+ currents of wild-type Nav1.5 and
the Y1767C cysteine mutant. In the absence of MTSET the peak
currents slowly increased after break-in due to a combination
of recovery from inactivation and intracellular dialysis of the
cells with pipette solution (Figures 1A,C). In the absence of
reagent, the peak currents of wild-type and Y1767C channels
increased an average of 29.1 ± 3.6% (n = 15) and 21.6 ± 2.6%
(n = 9), respectively. Including MTSET in the patch pipette
resulted in increased wild-type currents similar to reagent-
free controls (Figure 1B) indicating that in the absence of
inserted D4S6 cysteines the Nav1.5 channels are insensitive to
internally applied MTSET (O’Reilly and Shockett, 2012). This
contrasted with the Y1767C mutant where internal MTSET
produced a 42.1 ± 4.6% decrease in the Na+ current amplitude
(Figure 1D).
The MTSET inhibition of the D4S6 cysteine mutants was
quantiﬁed by calculating the ratio of the currents (P60/P1)
measured immediately after break-in (P1) and after 5 min of
internal MTSET exposure (P60). MTSET signiﬁcantly inhibited
the Na+ currents of the F1760C, V1763C, and Y1767C mutants
(Figure 2D). We also examined the eﬀects of MTSET on
the currents of cysteine mutants situated immediately adjacent
to these sites (S1759C, V1764C, M1766C). MTSET produced
similar inhibition of the S1759C/F1760C and V1763C/V1764C
pairs indicating that these adjacent cysteines are equally sensitive
to internal MTSET. The MTSET inhibition of Y1767C was
signiﬁcantly larger than the adjacent M1766C suggesting that
the latter residue may face away from the aqueous pore making
it less accessible to polar MTSET.
MTSET Produces Hyperpolarizing Shifts in
Steady-State Inactivation
The MTSET-induced reduction in the currents of the cysteine
mutants could result from decreased availability caused by
hyperpolarizing shifts in steady-state inactivation. Steady-
state inactivation was determined using 200 ms prepulses
to voltages between –160 and –50 mV. Figure 3 plots the
steady-state availability of the currents versus the prepulse
potential. The inactivation of wild-type channels had a midpoint
(V0.5) of –97 mV and slope factor (kv) of 5.7 mV. Internal
FIGURE 1 | Methanethiosulfonate reagent (MTSET) inhibition of D4S6
cysteine mutant. Cells were held at –140 mV and depolarized to –10 mV for
20 ms at 5 s intervals. Currents are shown immediately after whole-cell break-in
(P1) and after 5 min (P60). (A,C) In the absence of reagent the currents
increased 29.1 ± 3.6% (n = 15) for wild-type and 21.6 ± 2.6% (n = 9) for
Y1767C after 5 min. (B) Including 1 mM MTSET in the patch pipette had no
effect on wild-type currents. (D) Internal MTSET inhibited the Y1767C currents
by 42.1 ± 4.6% after 5 min.
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FIGURE 2 | Methanethiosulfonate reagent inhibition of D4S6 cysteine
mutants. (A,B) Homology model of the Nav1.5 pore-forming region (See
Materials and Methods). Model shows the orientation of the Nav1.5 D4S6
segment (blue) residues V1763 (purple), Y1767 (orange), and I1770 (cyan)
viewed from the side (A) and top (B) of the channel. The D2 segment is
shown in gray and the D1 (front) and D3 (back) segments were removed for
clarity. (C) Primary amino acid sequence of the Nav1.5 D4S6 segment.
Residues mutated to cysteine are shown in red. (D) The Na+ currents of
D4S6 cysteine mutants were measured immediately after break in (P1) and
after 5 min of internal 1 mM MTSET (P60). MTSET inhibition was calculated
from the ratio of the P60 and P1 currents [1–(IP60/IP1)∗100] and plotted versus
the D4S6 residue number (I1756–Y1767). Asterisks indicate significant
differences in the MTSET inhibition of the Na+ currents of adjacent pairs of
D4S6 cysteine mutants.
MTSET produced a slight hyperpolarizing shift in V0.5
(V0.5 = –3.8 mV) but no change in kv. In the absence
of reagent the midpoints and slope factors of the V1763C
and Y1767C mutants were similar to the wild-type channels
indicating that the cysteine substitutions at these positions do
not substantially alter inactivation. Internal MTSET shifted the
midpoints of V1763C and Y1767C inactivation (V0.5) by –31
and –23 mV, respectively and produced a 1.5-fold increase in kv
(Table 1).
The observed hyperpolarizing shifts in V1763C and Y1767C
steady-state inactivation could result from MTSET-induced
slowing of recovery from inactivation. In the absence of reagent
the recovery time course of the V1763C and Y1767C mutants
were exponential with time constants (τR) of 3.8 and 2.4 ms
respectively (Figure 4). MTSET delayed recovery and increased
the recovery time constants of both V1763C (12.6 ms) and
Y1767C (5.1 ms). The signiﬁcant 2–3 fold increase in τR
accounted for the slower recovery of the MTSET-modiﬁed
channels and contributes to the observed hyperpolarizing shifts
in steady-state inactivation (Table 1).
Fast Inactivation Promotes MTSET Inhibition
During the course of these experiments we observed that
depolarizing holding potentials (<–140 mV) appeared to
facilitate the onset of MTSET inhibition of the D4S6 cysteine
mutants (Figure 5). At –100 mV, the currents of the V1763C
and Y1767C mutants were completely inhibited in ≈2 min of
internal MTSET exposure. This contrasted with the –140 mV
holding potential where the MTSET inhibition required >5 min
to reach steady-state levels. Steady-state inactivation predicts
that the fraction of inactivated channels at –140 mV (V1763C:
0.9 ± 0.003%, Y1767C: 2.2 ± 0.02%) signiﬁcantly increases at –
100 mV (V1763C: 30.2 ± 1.7%, Y1767C: 54.8 ± 9.6%) for
both mutants. These data suggest that holding the channels
at more depolarized voltages where a larger fraction of the
channels are inactivated accelerates the onset of the MTSET
inhibition.
Fast Inactivation is Required for MTSET
Inhibition
The contribution of fast inactivation to MTSET inactivation was
further investigated by transferring the V1763C and Y1767C
mutations to an inactivation-deﬁcient background of Nav1.5
constructed by substituting cysteine for the native phenylalanine
(F1486C) of the D3–D4 linker IFM motif (Kellenberger et al.,
1996; Chahine et al., 1997). Internal MTSET has been shown
to rapidly modify the cysteine at position 1486 resulting is the
loss of fast inactivation. Internally applied MTSET abolished
the fast inactivation of the V1763C-ICM and Y1767C-ICM
mutant channels within seconds (<10 s) of break-in indicating
that MTSET rapidly diﬀuses from the pipette into the cell
(Figures 6B,C). Despite the presence of internal MTSET the peak
currents of the non-inactivating V1763C-ICM and Y1767C-ICM
channels gradually increased in amplitude similar to reagent-
free controls. Figure 6D shows that after 5 min of internal
exposure the normalized currents of MTSET-treated cells were
not diﬀerent from reagent-free controls.
Also shown is the eﬀect of internal MTSET on an alternative
non-inactivating Nav1.5 background (IQM) constructed by
replacing the phenylalanine of the IFM motif with glutamine
(F1486Q). In the absence of MTSET the inactivation of
the V1763C-IQM and Y1767C-IQM double mutants were
severely impaired resulting in channels that remain persistently
open at depolarized voltages (West Patton Scheuer Wang
Goldin Catterall 1992). Internal MTSET did not inhibit
the currents of the V1763C-IQM or Y1767C-IQM channels
(Figure 6D).
Mutations Near the C-Terminus of the D4S6
Disrupt Fast Inactivation
Situated near the C-terminus of the D4S6 segment is an isoleucine
(I1770) that bacterial models predict is located near the narrow
region of the cytoplasmic pore. Replacing this isoleucine with
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FIGURE 3 | Methanethiosulfonate reagent induces hyperpolarizing
shifts in steady-state inactivation of D4S6 cysteine mutants.
Steady-state inactivation was determined using 200 ms prepulses to
voltages between –170 and –50 mV and a standard test pulse to –10
mV for 20 ms to assess availability. The test pulses were normalized to
the current measured at –170 mV and plotted versus prepulse potential.
Data shown are for wild-type (A), F1760C mutant (B), V1763C mutant
(C), and Y1767C mutant (D) channels. The smooth curves are fits to
Boltzmann functions with the midpoints (V0.5) and slope factors (kv) listed
in Table 1.
TABLE 1 | Biophysical properties of D4S6 mutants.
Inactivation Recovery
V0.5 (mV) kv (mV) n τfast (ms) τslow (ms) Afast n
WT CTRL –97 ± 2.4 5.7 ± 0.4 12 2.7 ± 0.1 82 ± 11 0.95 11
MTSET –101.4 ± 1.3 6.6 ± 0.3 10 – – – –
F1760C CTRL –77.2 ± 1.6 5.3 ± 0.1 8 1.0 ± 0.01 33 ± 9 0.92 8
MTSET –89.4 ± 2.1 9.2 ± 0.4 13 1.5 ± 0.1 † 139 ± 65 † 0.96 13
V1763C CTRL –94.0 ± 1.6 6.6 ± 0.2 8 3.6 ± 0.2 78 ± 12 0.97 7
MTSET –125.1 ± 2.0 9.3 ± 0.2 8 13.0 ± 0.8 † – ∗ 1.00 8
Y1767C CTRL –97.3 ± 1.3 7.5 ± 0.1 7 2.1 ± 0.2 52 ± 14 0.93 7
MTSET –120.3 ± 1.8 10.5 ± 0.4 10 4.5 ± 0.4 † 44 ± 13 0.89 10
I1770C CTRL –93.5 ± 0.1 6.5 ± 0.1 7 1.7 ± 0.1 24 ± 4 0.96 11
† significant difference in pooled t-test (p < 0.05).
∗Recovery of MTSET-treated V1763C mutant was best fitted by a single exponential.
cysteine (I1770C) produced a small but signiﬁcant increase in
the persistent current (1.8 ± 0.1%, n = 7) by comparison to
wild-type channels (0.5 ± 0.04%, n = 13, t-test, p < 0.05).
I1770C also induced a slight depolarizing shift in steady-state
inactivation (V0.5 = 3.5 mV) and accelerated the recovery from
inactivation (Table 1). The I1770C mutation mildly disrupts fast
inactivation.
In the absence of MTSET the I1770C currents gradually
increased (19.5 ± 1.0%, n = 4) during the ﬁrst 3 min and
thereafter remained constant (Figure 7A). Including MTSET
in the patch pipette reduced the I1770C peak currents
and increased the residual non-inactivating current measured
after 25 ms of depolarization (Figure 7B). The peak and
persistent currents were normalized to the currents measured
immediately after break-in (P1) and plotted versus the duration
of MTSET exposure (Figures 7C,D). After 5 min, internal
MTSET signiﬁcantly reduced the peak currents 32.0 ± 2.1%
and increased the persistent current sixfold by comparison
to reagent-free controls (t-test, p < 0.05). The decrease in
I1770C peak current was similar to the MTSET inhibition
of the V1763C (23.7%) and Y1767C (42.1%) mutants. The
MTSET-induced increase in I1770C persistent current was
not observed with the other D4S6 mutants. Both the direct
eﬀects of the I1770C mutation on steady-state inactivation and
recovery along with the observed increase in persistent current
produced by internal MTSET suggest that residues situated near
the C-terminus of the D4D6 may play a unique role in fast
inactivation.
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FIGURE 4 | Methanethiosulfonate reagent slows recovery from
inactivation. Depolarizing prepulses to –10 mV for 20 ms were used to the
V1763C (A) and Y1767C (B) mutant channels. Cells were returned
to –140 mV for a variable interval (0.1 ms–250 ms) before applying a standard
test pulse to –10 mV for 20 ms. The test currents were normalized to the
recovery measured after 250 ms of recovery and plotted versus the recovery
interval. The smooth lines are biexponential curve fits with time constants and
relative amplitudes of the fast components listed in Table 1.
F1760C Impairs Fast Inactivation
While the majority of the D4S6 cysteine mutations did not
directly alter steady-state inactivation, F1760C produced a
signiﬁcant 20 mV depolarizing shift in inactivation midpoint
(Figure 3B; Table 1). The underlying cause of this shift
was investigated by measuring the time course of closed-state
inactivation of the F1760C mutant at voltages between –110
and –70 mV. The development of closed-state inactivation at
each voltage was with a ﬁtted single exponential (Figures 8A,B)
and the time constants plotted versus the prepulse voltage
(Figure 8). The resulting bell-shaped curves were ﬁtted to
a two-state model yielding estimates of the inactivation (kα)
and recovery (kβ) rate constants (Material and Methods). The
inactivation rate constants of the wild-type (β(0) = 24.7 ms−1)
and F1760C (β(0) = 12.7 ms−1) displayed modest two-fold
diﬀerence (Figure 8D). This contrasted with the recovery rate
constant of the F1760C mutant (α(0) = 9.1 × 10−6 ms−1),
which was an order of magnitude larger than recovery rate
constant of wild-type channels (α(0) = 8.3 × 10−7 ms−1). The
midpoint of F1760C steady-state inactivation (V0.5) predicted
FIGURE 5 | Methanethiosulfonate reagent inhibition is
voltage-dependent inhibition. The MTSET inhibition of the V1763C (A) and
Y1767C (B) mutants was examined while varying the holding potential
between –140 and –100 mV. Standard test pulses to –10 mV for 20 ms were
applied at 5 s intervals to assess current amplitude. The test currents were
normalized to the current measured immediately after break-in. Plotted are the
normalized currents for the V1763C and Y1767C mutants in the absence and
presence of 1 mM internal MTSET. Holding at a more depolarized voltage
(–100 mV) accelerated the onset of the MTSET inhibition by comparison to
the –140 mV holding potential. The data are the means and SEM of the
V1763C Control (n = 9), V1763C MTSET (n = 4), Y1767C control (n = 9), and
Y1767C MTSET (n = 14).
from β and α was –79 mV, similar to the value obtained using
a standard double-pulse protocols (Figure 3B, V0.5 = –77 mV).
These data indicate that the depolarizing shift in steady-state
inactivation observed with the F1760Cmutant is primarily driven
by rapid recovery from inactivation with little or change in
the onset of fast inactivation. Recent modeling suggests that
T206 of the NavMs channel (S1759 in Nav1.5) is situated within
a ﬂexible region of the D4S6 and may contribute to a hinge
that enables the C-terminus of the D4S6 to swing outward
during channel opening (McCusker et al., 2012). Mutating
residues within this region could alter hinge ﬂexibility and
may underlie the observed changes in F1760C steady-state
inactivation.
Internal MTSET produced a 19 ± 5% decrease in F1760C
current. Cysteine substitution at the adjacent position (S1759C)
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FIGURE 6 | Methanethiosulfonate reagent inhibition requires fast
inactivation. The V1763C and Y1767C mutations were transferred to an
inactivation deficient background of Nav1.5 created by replacing the conserved
F1486 of the interdomain D3–D4 linker with either cysteine or glutamine (see
text). (A) Shows the current of the ICM mutant lacking D4S6 mutations
measured during perfusion with standard pipette solution. (B) Current of the
V1767C-ICM mutant measured with 1 mM MTSET in the patch pipette.
(C) Current of the Y1767C-ICM mutant measured in the presence of MTSET.
(D) Currents were measured immediately after break in (P1) and after 5 min
(P60). The P60/P1 ratios of the V1763C-ICM and Y1767C-ICM mutants were not
different after 5 min of internal MTSET. Also shown are the P60/P1 ratios of the
non-inactivating V1763C-IQM and Y1767C-IQM mutants.
FIGURE 7 | Internal MTSET induces a persistent current in the
I1770C mutant. (A) The currents of the I1770C mutant measured
in reagent-free pipette solution. Currents are shown immediately after
break-in (P1) and after 0.5, 1, 3, 5, and 8 min (P100).
(B) Currents of the I1770C mutant with 1 mM MTSET in the
patch pipette. (C) Peak currents measured in the absence and
presence of MTSET. (D) Persistent current measured after 25 ms of
depolarization.
produced a slightly larger reduction (25 ± 5%) indicating
that the cysteines at positions 1759 and 1760 are sensitive to
MTSET. Unlike other D4S6 cysteine mutations, the F1760C-
ICM channels were reduced 10.2 ± 4.5% by MTSET suggesting
that the residue at this position remains accessible under
non-inactivating conditions. In addition to inhibiting the F1760C
current, internal MTSET induced a hyperpolarizing shift in
steady-state availability (V0.5 = –12.2 mV), a 1.7-fold increase
in kv and 1.5-fold slower recovery from inactivation (Table 1).
Overall, the eﬀects of internal MTSET on F1760C were relatively
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FIGURE 8 | The F1760C mutant alters closed-state inactivation. The
onset of closed-state inactivation was measured by applying variable length
prepulses (0–150 ms) to voltages between –110 and –70 mV. The cells were
then returned to –140 mV for 1 ms before assessing availability with a
standard test pulse to –10 mV for 20 ms. The peak currents were
normalized and plotted versus the prepulse pulse duration. (A,B) Onset of
closed-state inactivation of the wild-type and F1760C channels. The smooth
curves are fits to single exponential functions. (C) Time constants of the
wild-type and F1760C mutant obtained from panels (A,B) plotted versus the
prepulse potential. The smooth curve is a fit to a two state model yielding
the inactivation (β) and recovery (α) rate constants (See Materials and
Methods). (D) Plot of β and α as a function of voltage.
weak by comparison to those observed for the V1763C and
Y1767C mutants.
Discussion
The goal of this study was to investigate the role of the
D4S6 segment in the gating of Nav1.5 channels. Guided by
structural models of prokaryotic Na+ channels, D4S6 cysteines
were introduced at positions predicted to be exposed within
the cytoplasmic aqueous pore. Both the direct eﬀects of the
cysteine mutations and internal MTSET reagent on channel
gating were examined. With the exception of F1760C, the D4S6
cysteine mutations were well tolerated and produced only minor
changes in Na+ channel gating. Including MTSET in the patch
pipette reduced the current amplitudes, slowed recovery from
inactivation and produced hyperpolarizing shifts in steady-state
inactivation of channels with cysteines located near the near
the middle (V1763C) and C-terminus (Y1767C) of the D4S6.
Internal MTSET had no eﬀect on wild-type channels indicating
that the observed eﬀects do not result from the modiﬁcation of
endogenous cysteines. The MTSET-induced decrease in current
amplitude is primarily caused by slow recovery from inactivation
and the associated reduction in steady-state availability at
negative holding potentials (–140 mV). This is supported by data
showing that more depolarized holding potentials (–100 mV)
that favor inactivation accelerated the onset of the MTSET-
induced reduction in current (Figure 5). Overall, the ﬁndings
indicate that inactivated channels aremore susceptible toMTSET
modiﬁcation and that once modiﬁed the channels recover more
slowly from inactivation.
The eﬀects of MTSET are consistent with an important role
for V1763 and Y1767 in fast inactivation. This mechanism
was investigated by transferring V1763C and Y1767C to non-
inactivating Nav1.5 channels (ICM, IQM). Internal MTSET failed
to reduce the Na+ currents when the D4S6 cysteine mutations
were co-expressed in these non-inactivating backgrounds
(Figure 6). Because these channels remain persistently open at
depolarized voltages suggests that the entry of polar MTSET into
the cytoplasmic pore is not the rate limiting step in the MTSET
inhibition. Rather the data further supports the idea that fast
inactivation is required for the MTSET-induced reduction in
Na+ current amplitude.
I1770 is located near the C-terminus of the D4S6 segment. In
addition to reducing the peak currents of the I1770C mutant,
MTSET also increased the residual current measured near the
end of depolarizing pulses. MTSET did not alter the leak current
measured when the channels were returned to their holding
potential of –140 mV indicating that the I1770C channels
close normally at hyperpolarized voltages. Rather the observed
increase in residual current appears to be speciﬁc for the
activated or inactivated states of the channel. We hypothesize
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that MTSET modiﬁcation of the cysteine at this position 1770
enables the mutant channels to re-open from the normally
absorbing inactivated state. This was unique to I1770C and was
not observed with the other D4S6 mutations. I1770 is located
near a proposed narrow region of prokaryotic Na+ channel pore
and ﬁve residues upstream from the putative activation gate
(Bagneris et al., 2014). Our data suggests that residues within this
region may play a speciﬁc role in Na+ channel inactivation.
Methanethiosulfonate reagent is a positively charged reagent
that covalently modiﬁes cysteine residues exposed within
aqueous environments (Vedantham and Cannon, 2000).
Residues located within hydrophobic environments, such as
those that are oriented away from the aqueous pore or those
buried at protein interfaces, are generally insensitive to polar
MTSET. Our ﬁndings are consistent with a mechanism in
which the internally applied MTSET covalently modiﬁes the
V1763C and Y1767C cysteines resulting in slower recovery from
inactivation, hyperpolarized shifts in steady-state inactivation
and decreased availability of the channels. Moreover, the data
show that MTSET modiﬁcation is favored by depolarization
suggesting that the cysteinyl side chains are more accessible
when the channels are inactivated. The data indicate that
the V1763C and Y1767C residues are preferentially exposed
within cytoplasmic aqueous pore when the channels are
inactivated. Modiﬁcation of these residues with a cation
adduct appears to stabilize these residues within the aqueous
pore resulting slower recovery from inactivation. Y1767 is
a well-known component of the Nav1.5 local anesthetic
binding site (O’leary and Chahine, 2002; Huang et al.,
2011). We speculate that exposure of Y1767 within the
cytoplasmic pore of inactivated channels may contribute to
the state-dependent binding of local anesthetics while drug
binding to its aromatic sidechain may stabilize the aqueous
exposure of this residue resulting in slower recovery from
inactivation.
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